SMO inhibitors are a class of drugs that target the Smoothened (SMO) receptor, a crucial component of the Hedgehog (Hh) signaling pathway. This pathway plays a key role in cellular proliferation, differentiation, and survival. Dysregulation of the Hh pathway has been implicated in several types of cancer, making SMO inhibitors a promising therapeutic approach.
